Back
Jones Lang LaSalle, Inc. Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison
Buy
75
JLL
Jones Lang LaSalle, Inc.
Last Price:
$346.10
Seasonality Move:
9.23%
Sell
34
CRNX
Crinetics Pharmaceuticals, Inc.
Last Price:
$53.22
Seasonality Move:
-13.28%
Buy
75
Jones Lang LaSalle, Inc. (JLL)
is a Buy
Is Jones Lang LaSalle, Inc. a Buy, Sell or Hold?
-
The current Jones Lang LaSalle, Inc. [JLL] share price is $346.28. The Score for JLL is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
-
JLL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX)
is a Sell
Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JLL Stock Price Chart
What is Jones Lang LaSalle, Inc.'s stock price today?
-
The Jones Lang LaSalle, Inc. share price today is $346.28The current trend is moderately bullish and JLL is experiencing slight selling pressure.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals, Inc.'s stock price today?
-
The Crinetics Pharmaceuticals, Inc. share price today is $53.24Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.
JLL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.01 | Buy |
| Relative Strength Index (14 RSI): | 60.12 | Buy |
| Chaikin Money Flow: | -145240 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (328.84 - 345.42) | Buy |
| Bollinger Bands (100): | (295.75 - 330.09) | Buy |
CRNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.28 | Buy |
| Relative Strength Index (14 RSI): | 65.68 | Buy |
| Chaikin Money Flow: | -209678 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.25 - 50.15) | Buy |
| Bollinger Bands (100): | (35.32 - 47.44) | Buy |
JLL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 343.9 | Buy |
| 20-day SMA: | 339.92 | Buy |
| 50-day SMA: | 322.2 | Buy |
| 200-day SMA: | 277.73 | Buy |
| 8-day EMA: | 345.47 | Buy |
| 20-day EMA: | 339.37 | Buy |
| 50-day EMA: | 326.69 | Buy |
| 200-day EMA: | 291.36 | Buy |
CRNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.77 | Buy |
| 20-day SMA: | 48.57 | Buy |
| 50-day SMA: | 45.67 | Buy |
| 200-day SMA: | 36.1 | Buy |
| 8-day EMA: | 49.69 | Buy |
| 20-day EMA: | 48.35 | Buy |
| 50-day EMA: | 45.87 | Buy |
| 200-day EMA: | 40.28 | Buy |
Jones Lang LaSalle, Inc. Earnings Growth & JLL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.96 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.96 per share, and an increase next year of $2.87 per share.
Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.
Jones Lang LaSalle, Inc. Technical Analysis
| Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 24 | 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Crinetics Pharmaceuticals, Inc. Technical Analysis
| Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 23 | 24 | 26 | 29 | 30 | 31 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||